Syndicated from http://www.stm-publishing.com/
February 13, 2018
Reprints from peer-reviewed medical journals help pharma engage healthcare professionals and patients – and provide the essential clinical evidence behind marketing claims – yet their use has been in decline over many years.
Is technology about to disrupt the commercial content space as it did for research information over a decade ago and what are the key implications and opportunities this creates?
This one day Pharma Reprints Summit brings together the key stakeholders in the medical content and marketing space to meet and to learn from one another.
Presentations from stakeholders include the following topics:
What is the value of clinical evidence for HCPs and patients?
What role does peer-reviewed content play within a digital multichannel approach?
The challenges and opportunities of sharing, compliance and copyright?
The impact of value transfer and the sunshine act.
Tracking, metrics and measuring ROI for both pharma and content providers.
The event will be held at Cliveden, an iconic 17th century stately home and now one of the world’s finest hotels.
“We are delighted to be staging the Pharma Reprints Summit. This one day event will see participants from around the world engaging in discussions, networking and knowledge transfer on the critical issue of delivering scientific evidence to health care professionals. This is the first in a series of specialist events from the LII team.” said Clive Snell, MD, Info International.
To find out more about this event go to http://info-international-events.co.uk/#pharma-reprints-summit
Info International Ltd, +44(0)1628 97950